Taken together, MMP-3 O-glycan is highly α-2,6-sialylated in the RA joint lesion, and the ACG/Jacalin index, which reflects changes in sialylation, may serve as a new RA disease activity biomarker. This evidence concerns the gene MMP3 and rheumatoid arthritis.